<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01248143</url>
  </required_header>
  <id_info>
    <org_study_id>FPP and TEA IN DIABETES</org_study_id>
    <nct_id>NCT01248143</nct_id>
  </id_info>
  <brief_title>Molecular and Clinical Effects of Green Tea and Fermented Papaya Preparation on Diabetes and Cardiovascular Diseases</brief_title>
  <official_title>Molecular and Clinical Effects of Green Tea and Fermented Papaya Preparation on Diabetes and Cardiovascular Diseases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Touro College</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Mauritius</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mauritius Cardiac Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mauritius Ministry of Health and Quality of Life</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Osato Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Societe Uniniere de Bois Cheri</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mauritius Research Council</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Vienna</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Touro College</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Type 2 diabetes is common in ethnic and, minority groups in developing and developed
      countries such as Africans, African Americans, Asians, Native Americans, Hispano-Latinos and
      Alaskan indians. A randomized controlled study to assess the efficacy of fermented papaya
      preparation and green tea infusates in latent diabetes (individuals newly diagnosed as
      diabetics) is proposed. Glycation products from excess glucose autooxidation can chemically
      modify DNA causing mutations and cause complex DNA rearrangements. Advanced glycation
      end-products which play a role as proinflammatory mediators in gestational diabetes can
      accelerate vascular occlusion by quenching the vasodilating agent nitric oxide. Interaction
      with high-affinity receptors located on monocytes and macrophages can enhance the production
      of free radicals and reactive oxygen/nitrogen species, the secretion of tumor necrosis
      factor-Î±, interleukin-1 and insulin-like growth factor I which can proliferate endothelial,
      mesangial and smooth muscle cells and hence contribute significantly to the pathogenesis of
      cardiovascular complications. The clinical markers include C-reactive proteins (inflammation
      indicators), protein C (markers of reno vascular injury), uric acid, natriuretic peptides,
      and the integrity of isolated adipocytes, glucose levels, lipid indices (triglycerides, total
      cholesterol, VLDL, HDL and LDL). Given that decreased functional activity of activated
      protein C affects the permeability of the glomerular capillary wall and enhances apoptosis of
      glomerular endothelial cells and adipodocytes, this has relevance to the pathophysiology of
      diabetic nephropathy. A second phase of the study is expected to commence after the first 16
      weeks in order to assess the ability of the dietary factors to modulate atheroma formation
      and the integrity of drug therapy (upon commencement of treatment)on the prognosis of
      diabetes. This will be expected to last up to 3 years.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2010</start_date>
  <completion_date type="Actual">March 2011</completion_date>
  <primary_completion_date type="Actual">March 2011</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assess the effects of green tea and FPP on the levels of C-reactive proteins</measure>
    <time_frame>3 months</time_frame>
    <description>The pathophysiology of atherosclerosis and other cardiovascular events have associated inflammatory processes. The levels of plasma high-sensitivity (hs) C-Reactive Protein, an acute phase reactant produced in the liver, known to rise in inflammatory reactions are widely suggested to be a predictor of coronary events; and increased uric acid levels (hyperuricemia) are considered to be a risk factor in many clinical conditions including hypertension, cardiovascular events, diabetes mellitus, stroke, and metabolic syndrome.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assess the effect of green tea and fermented papaya preparation on development of atheroma and drug therapy outcomes</measure>
    <time_frame>3 years</time_frame>
    <description>Carotid artery angioplasty and stenting has been proposed as an alternative therapy for patients requiring treatment of carotid artery stenosis as opposed to the &quot;gold standard&quot; surgical intervention, carotid endarterectomy. The second phase of the study will investigate the possible role of green tea and fermented papaya preparation in modulating the risk of stroke by assessing the extent of atheroma using both echocardiography and CT angiography. Patients will be on medication and the therapeutic outcome will be assessed.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">300</enrollment>
  <condition>Assess the Effect of Green Tea on Diabetes</condition>
  <condition>Assess the Effect of Fermented Papaya Pretration on Diabetes</condition>
  <condition>Effects of Green Tea and FPP on C-reactive Proteins</condition>
  <condition>Effects of Green Tea and FPP of Lipid Profiles in Diabetes</condition>
  <condition>Effect of Green Tea and FPP on Atheroma Formation</condition>
  <arm_group>
    <arm_group_label>Green tea</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>FPP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Green tea</intervention_name>
    <description>9 gram per day</description>
    <arm_group_label>Green tea</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>FPP</intervention_name>
    <description>2 sachets twice daily</description>
    <arm_group_label>FPP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Individuals at risk of diabetes 35-65 years of age male or female

        Exclusion Criteria:

          -  Smokers or those who have stopped smoking 6 months before the study

          -  Daily alcoholic intake exceeding 4 standard drinks

          -  Post menopausal women currently under hormone replacement treatment

          -  Hypertension (&gt;140/90 mm Hg)

          -  individuals outside the age range 35-60
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Okezie I Aruoma, PhD DSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Touro College of Pharmacy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Touro College of Pharmacy</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10027</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Vienna</name>
      <address>
        <city>Vienna</city>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Mauritius</name>
      <address>
        <city>Reduit</city>
        <country>Mauritius</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Mauritius</country>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Bahorun T, Luximon-Ramma A, Gunness TK, Sookar D, Bhoyroo S, Jugessur R, Reebye D, Googoolye K, Crozier A, Aruoma OI. Black tea reduces uric acid and C-reactive protein levels in humans susceptible to cardiovascular diseases. Toxicology. 2010 Nov 28;278(1):68-74. doi: 10.1016/j.tox.2009.11.024. Epub 2009 Dec 4.</citation>
    <PMID>19963031</PMID>
  </reference>
  <results_reference>
    <citation>Bahorun T, Luximon-Ramma A, Neergheen-Bhujun VS, Gunness TK, Googoolye K, Auger C, Crozier A, Aruoma OI. The effect of black tea on risk factors of cardiovascular disease in a normal population. Prev Med. 2012 May;54 Suppl:S98-102. doi: 10.1016/j.ypmed.2011.12.009. Epub 2011 Dec 16.</citation>
    <PMID>22198621</PMID>
  </results_reference>
  <results_reference>
    <citation>Somanah J, Aruoma OI, Gunness TK, Kowelssur S, Dambala V, Murad F, Googoolye K, Daus D, Indelicato J, Bourdon E, Bahorun T. Effects of a short term supplementation of a fermented papaya preparation on biomarkers of diabetes mellitus in a randomized Mauritian population. Prev Med. 2012 May;54 Suppl:S90-7. doi: 10.1016/j.ypmed.2012.01.014. Epub 2012 Feb 11.</citation>
    <PMID>22330753</PMID>
  </results_reference>
  <results_reference>
    <citation>Toolsee NA, Aruoma OI, Gunness TK, Kowlessur S, Dambala V, Murad F, Googoolye K, Daus D, Indelicato J, Rondeau P, Bourdon E, Bahorun T. Effectiveness of green tea in a randomized human cohort: relevance to diabetes and its complications. Biomed Res Int. 2013;2013:412379. doi: 10.1155/2013/412379. Epub 2013 Sep 12.</citation>
    <PMID>24102055</PMID>
  </results_reference>
  <results_reference>
    <citation>Somanah J, Bourdon E, Rondeau P, Bahorun T, Aruoma OI. Relationship between fermented papaya preparation supplementation, erythrocyte integrity and antioxidant status in pre-diabetics. Food Chem Toxicol. 2014 Mar;65:12-7. doi: 10.1016/j.fct.2013.11.050. Epub 2013 Dec 5.</citation>
    <PMID>24316314</PMID>
  </results_reference>
  <results_reference>
    <citation>Aruoma OI, Somanah J, Bourdon E, Rondeau P, Bahorun T. Diabetes as a risk factor to cancer: functional role of fermented papaya preparation as phytonutraceutical adjunct in the treatment of diabetes and cancer. Mutat Res. 2014 Oct;768:60-8. doi: 10.1016/j.mrfmmm.2014.04.007. Epub 2014 Apr 24. Review.</citation>
    <PMID>24769427</PMID>
  </results_reference>
  <verification_date>November 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 24, 2010</study_first_submitted>
  <study_first_submitted_qc>November 24, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 25, 2010</study_first_posted>
  <last_update_submitted>November 14, 2014</last_update_submitted>
  <last_update_submitted_qc>November 14, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 17, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Touro College</investigator_affiliation>
    <investigator_full_name>Dr Okezie I Aruoma</investigator_full_name>
    <investigator_title>Professor of Pharmaceutical and Biomedical Sciences</investigator_title>
  </responsible_party>
  <keyword>Green Tea</keyword>
  <keyword>Fermented papaya preparation</keyword>
  <keyword>Diabetes</keyword>
  <keyword>Cardiovascular diseases</keyword>
  <keyword>Atherosclerotic plaques</keyword>
  <keyword>Glucose</keyword>
  <keyword>Dietary supplements and functional foods</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Plaque, Atherosclerotic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

